Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)


In 2009, the global Osteoporosis drug market was worth USD 6.8 billion, with Bisphosphonate class of drugs leading the market. In the overall Bisphosphonate, ibandronate (Bonviva/Boniva; Roche) and zoledronate (Aclasta/Zometa; Novartis) accounted largest share in class, respectively, and showed an average sales growth rate of about of 20% in the past 2 years.
Amgen’s Denosumab is the recent entrant to the Osteoporosis treatment market, following its approval from the U.S. and European Union (also approved for bone loss associated with prostate cancer). Denosumab is expected to compete directly with the Bisphosphonate drug class. However, initial uptake of Denosumab is likely to be as second-line therapy, mostly in patients who are intolerant to Bisphosphonate. In addition to the treatment of Osteoporosis, there is substantial potential for Denosumab for treating bone loss in patients with cancer. Denosumab market is expected to reach USD 3.8 billion in 2015.
Our research indicates that the Osteoporosis drug pipeline is going strong with various phases of clinical development. Phase III has first-in-class products such as odanacatib, which possess a novel mechanism of action to combat Osteoporosis. Aprela is another drug in the stage of development.
The Chinese Osteoporosis drug market is expected to grow at a CAGR of 13.5% from 2010 to 2015. Increased prevalence of Osteoporosis among Chinese female population is the principal growth driver of the Osteoporosis drug market. The other key growth drivers for Chinese Osteoporosis market include increasing elderly aged population, rising living standards of the Chinese people and increasing awareness and bone health education.
Geographical analysis of Chinese Osteoporosis drug market shows that there is a huge growth potential for Osteoporosis drug in many cities including Shanghai, Beijing, Guangzhou, and Hangzhou.
To gain a competitive advantage, market players should develop cost-competitive drugs with easy dosage pattern, which promote bone building effectively. Large numbers of patients are unable to comply with the strict dosage schedule of traditional Osteoporosis drugs. Further research and development can address the unmet need by coming up with drugs that have a convenient dosage schedule with better efficacy and safety compared to traditional treatment of Osteoporosis.
After 2012, the Parathyroid Hormone and SERM Osteoporosis drug class market is expected to decline because of anticipated growth of Prolia (Denosumab), which will largely affect other drugs’ market share.
Scope and Overview
The objective of the study on “Global and China Osteoporosis Drug Market Analysis and Forecast (2009 – 2015)” is to gain detailed market insights for key Osteoporosis drugs market segments. The market is analyzed on the basis of growth trends, ongoing developments, market penetration and revenue share. The report also covers the strategies followed by “Osteoporosis Drugs Market” players.
Segmentation & Analysis
The report segments and analyzes the “Osteoporosis Drugs Market” on the basis of following sub-categories:
• Geographic Markets
o Global
o China
• By Segment
o Bisphosphonate Drugs
o SERM Drugs
o Parathyroid Hormone Drugs
o Calcitonin Drugs
o Denosumab Drugs
This section provides in-depth analysis of Osteoporosis Drugs Market size and growth forecast for each drug category, driving factors and challenges prevailing in the overall and at the micro market levels, and opportunities and future outlook for all the levels.
Table Of Content
CHAPTER 1 EXECUTIVE SUMMARY
CHAPTER 2 CHINA OSTEOPOROSIS MARKET ANALYSIS, 2009 – 2015
2.1 MARKET OVERVIEW
2.2 50+ CHINESE POPULATION GROWTH TREND 2007 – 2050
2.3 CHINA POPULATION AGE STRUCTURE, 2010
2.4 CHINESE POPULATION WITH OSTEOPOROSIS, 2008 – 2050 (MILLION)
2.5 DRIVING FACTOR ANALYSIS OF CHINA OSTEOPOROSIS MARKET
2.5.1 BARGAINING POWER OF CUSTOMERS: MEDIUM/HIGH
2.5.2 BARGAINING POWER OF SUPPLIERS: LOW
2.5.3 THREAT OF SUBSTITUTE PRODUCTS: MEDIUM
2.5.4 THREAT OF ENTRY OF NEW COMPETITORS: LOW
2.5.5 INTENSITY OF COMPETITIVE RIVALRY: HIGH
2.6 APPROVED OSTEOPOROSIS TREATMENT LANDSCAPE
2.7 COMPETITIVE STRATEGIES
CHAPTER 3 CHINA OSTEOPOROSIS DRUGS MARKET
3.1 MARKET OVERVIEW
3.2 CHINESE OSTEOPOROSIS MARKET ESTIMATE & FORECAST, 2009 – 2015
3.3 DRIVERS
3.3.1 INCREASING AWARENESS OF OSTEOPOROSIS AMONG PATIENTS AS WELL AS                      PHYSICIANS
3.3.2 IMPROVEMENT IN THE RATE OF DIAGNOSIS
3.3.3 BABY BOOMER GENERATION AND INCREASED LIFE EXPECTANCY
3.3.4 HEREDITARY EFFECT AND SEDENTARY LIFESTYLE
3.3.5 SMOKING AND ALCOHOLISM
3.4 RESTRAINTS AND OPPORTUNITIES
3.4.1 REIMBURSEMENT POLICIES
3.4.2 PATIENT AND PHYSICIAN EDUCATION
3.4.3 SIGNIFICANT CLINICAL UNMET NEEDS
3.5 BISPHOSPHONATE DRUGS MARKET ANALYSIS & FORECAST, 2009 – 2015
3.6 SERM DRUGS MARKET ANALYSIS & FORECAST, 2009 – 2015
3.7 PARATHYROID HORMONE DRUGS MARKET ANALYSIS & FORECAST, 2010 – 2015
3.8 CALCITONIN DRUGS MARKET ANALYSIS & FORECAST, 2009 – 2015
3.9 DENOSUMAB DRUGS MARKET ANALYSIS: NOT COMMERCIALIZED
CHAPTER 4 GLOBAL OSTEOPOROSIS DRUGS MARKET ANALYSIS AND FORECAST, 2009 – 2015
4.1 MARKET OVERVIEW
4.2 GLOBAL OSTEOPOROSIS MARKET ESTIMATE & FORECAST, 2009 – 2015
4.3 GLOBAL BISPHOSPHONATE DRUGS MARKET ANALYSIS & FORECAST,
2009 – 2015
4.4 GLOBAL SERM DRUGS MARKET ANALYSIS & FORECAST, 2009 – 2015
4.5 GLOBAL PARATHYROID HORMONE DRUGS MARKET ANALYSIS & FORECAST, 2009 – 2015
4.6 GLOBAL CALCITONIN DRUGS MARKET ANALYSIS & FORECAST, 2009 – 2015
4.7 GLOBAL DENOSUMAB DRUGS MARKET ANALYSIS & FORECAST, 2010 – 2015
4.8 PIPELINE DRUGS IN OSTEOPOROSIS MARKET ANALYSIS
4.8.1 ODANACATIB (MK 0822)
4.8.2 APRELA (BAZEDOXIFENE)
CHAPTER 5 RECOMMENDATION
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Ms Amita
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

» Read More...

Minimally Invasive Surgery Market And Prostate Cancer Market In North America And Europe 2011 To 2016


The prostate cancer minimally invasive surgical device market in North America and Europe is estimated to be $14.2 billion in 2011 and expected to reach $24.9 billion in 2016 at a CAGR of 11.9% over the period 2011 to 2016. The monitoring and visualization segment is the leading market contributor with a share of around 38% in 2011.
Browse full report at:  Minimally Invasive Surgery Market
Prostate cancer is the second most leading cause of cancer associated mortality among men after lung cancer. In 2010, more than 1.9 million people have been diagnosed with the prostate cancer across the world. African Americans and whites are most affected with this disease. Old age, heredity, lifestyle aspects such as smoking and diet rich in red meat are the major factors increasing the risk of getting affected with the disease.
Prostate Cancer Minimally Invasive Surgery Market
Prostate Cancer Minimally Invasive Surgery Market
The estimated market of North America & Europe minimally invasive prostate cancer surgical device is USD 14.2 billion in 2011 and expected to realize a growth of 11.9% over the period of 2011 to 2016. U.S. is the leading market of minimally invasive prostate cancer surgical devices with an estimated share of around 56% (USD 8 Billion) in 2011and expected to become USD 13 billion (52%) in 2016. Germany is the second high growth market and is the leading market in Europe. It has the estimated market share of about 11% in 2011and is expected to reach USD 3 billion in 2016.
Digital Rectal Exam (DRE), Prostate Biopsy, Prostate Specific Antigen (PSA) blood test, bone scan, ultrasound, CT scan, MRI, lymph node biopsy and ProstaScint monoclonal antibody scanare some of the methods used to diagnose the prostate cancer. Among the surgical techniques, minimally invasive have become quite popular in the last decade.Laparoscopy, cryosurgery, brachytherapy and robotic surgery are the commonly practices surgical techniques while performing minimally invasive surgeries for the treatment of prostate cancer. Laparoscopy has the comparative high adoption rate among the surgeons, while surgical robot has significantly emerged as the top preference in past decade. In spite of high cost of robots (close to USD 1.5 million), their adoption has considerably increased due to better precision, dexterity, improved surgery control, reduced risk of surgical side effects such as impotency, shorter hospital stay, lesser pain, quicker recovery.
Prostate cancer minimally invasive surgery market in North America & Europe is quiteconsolidated. Global players like Ethicon Endo Surgery, Covidien, Intuitive Surgical, Boston Scientific Corporation and Carefusion Corporation holds over 4/5th of the market in 2010. Ethicon Endo Surgery is the market leader with control over 1/3rdof market, followed by Covidien. Further, Intuitive Surgical, Boston Scientific Corporation, Carefusion Corporation and Olympus are closely positioned with shares between 13% and 5%.
Scope and Overview
The objective of the study on “Minimally Invasive Prostate cancer Surgery Market in North America and Europe” is to gain detailed market insights for minimally invasive surgical techniques and devices used to treat prostate cancer in developed economies where the reported cancer incidence is very high. The market is analyzed on the basis of growth trends, ongoing developments, market penetration and revenue share.The report also covers the strategies followed by “Minimally Invasive Prostate cancer Surgery Market in North America and Europe” players.

» Read More...

Baby Food Market: Global Analysis And Forecast 2007 to 2017


Globally as parents are increasingly becoming aware the nutritional requirement in their baby’s food, they are rapidly turning towards more products that enhances the development of their babies throughout the early development stage. Parents with time constraints & concerned about their babies adequate nutrition and all round development are more demanding and also seek clear and timely communication about baby food products.
While birth rates declining in developed markets, new and emerging markets such as India, Brazil and Middle East & African countries has opened up growth gates for baby food market. Enhanced participation of woman in work and fast paced lifestyle has enhanced the adoption of packaged baby food in these regions. Moreover, high competition and growing challenges is also pushing parents to look for high nutritional food for their babies to support their early stage growth. Status symbol also becoming one of the major causes for the adoption of packaged baby food in developing nations.
The Global Baby Food & Pediatric Nutrition Market in 2011 is estimated be worth USD 38,180.9 Million growing with a CAGR of 7.97% during 2007 – 2011 from USD 28,100.0 Million in 2007. The Market is estimated to be worth USD 41,521.7 Million in 2012 and is forecasted to reach USD 63,681.0 Million in 2017. Asia Pacific is expected to account for the largest share of revenue – i.e. 40.20% – of Global Baby Food & Pediatric Nutrition Market revenue at USD 16,692.5 million in 2012. The segment is further expected to reach USD 30,149.1 million in 2017 with a CAGR of 12.55% during 2012 – 2017. The region is also expected to account for largest share of volume – i.e. 37.82% – ofGlobal Baby Food & Pediatric Nutrition Market Volume at 1,223.9 thousand tonnes in 2012. The segment is expected to reach 1,846.3 thousand tonnes in 2017 with a CAGR of 8.57% during 2012 – 2017. The segment is also expected to have the highest growth rate during the same period.
The global baby food market is primarily categorized on the basis of products, types, nutritional values and ingredients. This report categorizes the baby food and pediatric nutrition market into seven geographic regions namely: Asia – Pacific, Western Europe, Eastern Europe, North America, Latin America, Middle East & Africa and Australasia.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
Tel: +91-20-32405329
Email: sales@transparencymarketresearch.com

» Read More...

New Agneepath 2012: Movie Review


Movie Name:Agneepath
Critic Rating:
Viewer Rating:
Click here to vote
302
Click here to vote
113
Star Cast:Hrithik Roshan, Sanjay Dutt, Rishi Kapoor, Priyanka Chopra, Zarine Wahab and Om Puri.
Director:Karan Malhotra
Producer:Karan Johar and Hiroo Johar.
Music Directer:Ajay Gogavale and Atul Gogavale.
Genre:Drama, Action.

StoryStory: Set initially in a village called Mandwa in India, Agneepath which eventually moves to Mumbai, is a simple story of Vijay Dinanath Chauhan (Hrithik Roshan) who wants to take the revenge of his father Dinanath Chauhan’s murder from Kancha (Sanjay Dutt). In the journey to achieve his goal, he stumbles upon Rauf Lala (Rishi Kapoor) who becomes his Godfather. Also, meanwhile, he grows up with girl in neighborhood, Kaali (Priyanka Chopra), who eventually becomes his love interest. Now, how will Vijay accomplish his task is the rest of the story!

Story Treatment: Comparisons are inevitable when a classic like Agneepath is remade. Now, the question remains, will Agneepath surpass the expectations and live up to the hype it has created so far? Well, first of all, current Agneepath isn’t the exact replica of the original one in terms screenplay. New entrants like Rauf Lala add new interesting dimensions to the story. This Hrithik-Sanjay starrer flick is a collage of some impactful moments but fitted in the most haphazard manner which makes it impact less at many moments. Irrelevant sequences like intimacy between Hrithik-Priyanka and overtly dragged brother-sister reunion sequence further add to the misery.

Star Cast: Hrithik Roshan is confidence-personified and complements his counterpart Sanjay Dutt who seemingly looked more powerful as an actor in promos. Sanjay Dutt as Kancha was anticipated to give ‘A’ performance and he lives up to the hype. But, certainly above them is Rishi Kapoor who impresses with his flawless power-packed performance. Priyanka Chopra is brilliant in her small but pivotal role though, the film could survive without her presence. Zarine Wahab and Om Puri play their part well.

Direction: Karan Malhotra still has a long way to go as he comes across as very na├»ve with his approach towards direction. His act loses threads at most places. But, one can’t take away the credit of creating some historical moments like a beautifully shot fight between Hrithik and Rishi. Also, the way Hrithik reveals his real identity as Dinanath’s son to Kancha through a messenger. And last but not the least, the climax where Vijay takes on Kancha leading to latter’s brutal death. Only thing is wish, these moments were alligned properly with no loopholes to make it a smooth watch for the viewer.

Music/ Cinematography/ Dialogues/ Editing: Barring Chikni Chameli, where Katrina Kaif sets the screen ablaze, none of the songs register. Cinematography gets full marks for capturing the expressions and experimenting with different camera angles. Dialogues are mediocre and crisp editing could have helped in curbing the lengthy duration of the film.

3 Ups and 3 Downs: Stupendous performances, fresh storyline despite a remake, Chikni Chameli song and cinematography are strengths of the film. Music, editing, long duration are the weak points.
On the whole, Agneepath totally rests on star power which will lure the cine-goers to halls but how far will it impress them remains to be seen.

» Read More...

Cardiovascular Diagnostic Devices Market and Cardiovascular Devices Market 2011 to 2016

Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. It also includes the devices such as interventional cardiology, cardiac rhythm management, cardiac assist devices, peripheral vascular devices, cardiac surgery, devices used to monitor cardiac events and cardiac prosthetic devices to record the electrophysiological impulses of the heart and to analyze and diagnose any abnormality related to the cardiac function.
Cardiovascular Monitoring and Diagnostic devices are used to detect and provide feedback of abnormal episodes of electrical functioning of the heart. The Cardiovascular  Monitoring & Diagnostic devices include Holter and event recorders, ECG recorders and  ECG stress testing.


This report analyses the Cardiovascular Monitoring and Diagnostic devices into four sub- categories, which includes:
ECG monitoring equipment is used to record the Electrocardiogram, ECG which are the intrinsic electrical signals generated in the heart.
ECG stress test or Tread Mill Test (TMT) is a diagnostic device used to record the ECG by subjecting the heart to excessive workload. These systems measure the performance of the heart at various stress levels and help physicians in disease diagnosis and deciding treatment protocol.
Event monitors or recorders are devices used to record only the abnormal events of the ECG over an extended period of time.
Holter monitors are devices used to record the ECG for a 24-hour period and to identify abnormal episodes of the ECG.


The report forecasts all the sub-categories by regional markets. It also identifies and analyzes the market trends, drivers, inhibitors and opportunities present in each. The key players and their growth strategies have also been analyzed and explained in the  report.

SCOPE OF THE REPORT
The report categorizes global Cardiovascular Monitoring and Diagnostic devices market into four main subcategories: ECG Monitoring Devices, Holter Monitoring Devices, ECG Stress Testing Devices, and Event Monitoring Devices. In addition to market sizes and forecasts, the report identifies and analyzes trends and opportunities for each of the twelve submarkets; providing 48 market tables for submarkets in the U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, Australia, China, India and Brazil.

RESEARCH METHODOLOGY
Key market players were identified using Transparency Market Research, while market sizes were calculated using the bottom-up approach with market trends and penetration percentages verified through various research reports, analysts’ articles, previously published reports on the industry and key competitor companies investor presentations. We also analyzed the annual reports of key players and used their revenues for market estimations.


OBJECTIVES OF THE RESEARCH
·         Defining and measuring Global Cardiovascular Monitoring and Diagnostic devices market  with respect to products, services and technologies
·         To analyze the market structure by figuring out diverse sub-segments of the Global  Cardiovascular Monitoring and Diagnostic devices market
·         Forecast revenues of the Global Cardiovascular Monitoring and Diagnostic Devices market  and its diverse submarkets with respect to twelve main geographies of the U.S., Canada,  the U.K., Germany, France, Italy, Spain, Japan, Australia, China, India and Brazil
·         Recognizing the major market tendency and features driving or hindering growth of the  global Cardiovascular Monitoring and Diagnostic devices market and its diverse  submarkets
·         Strategically analyze each submarket with respect to individual growth trends and  contribution to the overall Cardiovascular Monitoring and Diagnostic devices market
·         Analyze opportunities in the market for stakeholders by identifying high-growth segments  of the global Cardiovascular Monitoring and Diagnostic devices market
·         Follow and evaluate competitive growth like alliances, joint ventures, mergers and  acquisitions in the global Cardiovascular Monitoring and Diagnostic devices industry.

» Read More...

Weight Management Market And Weight Loss Market


Overweight and obesity have become the major issues that were haunting the well-being of the people and there are various causes related to this menace. This global phenomenon can be controlled. If not completely cured; partly by the Weight Management Services (a subset of the global Weight Management market) that helps the overweight and obese population to manage their BMI factor to lead to balanced life.

The sub-sectors of the Weight Management Services are:
  •  Professional Weight Management Advisory
  •  Slimming Centers
  •  Invasive and non-invasive surgeries for weight loss
The push in the health reforms by various governments of the developed and developing nations in order to enhance the quality of living and to bring down the medical costs, coupled with the changing mindset of the people (preferably the urban-sedentary class) has brought this industry into the spot light, and this report portrays their potential and opportunities prevailing in this industry as a whole.
Notable key facts in regards to the overweight and obese population have been highlighted in this report. Region wise data (such as U.S.A., Europe, Asia and RoW), classification of BMI as per the World Health Organization (WHO), the implications of being overweight and obese, and the drivers of this industry, etc., are covered in detail. The detailed classification of the services in the Weight Management Services is a highlight of this work and followed by the company profiles in detail. In the midst of this research, the investor community is also considered by studying what attracts the investors to this industry.


To bring-in comprehensiveness into this work, emphasis has been laid on the market dynamics, services available, demographic facts and global trends in the weight management services industry. The description of the organizations that are into the slimming centers, related professional services and hospitals that are into the weight loss surgeries have been thoroughly regarded. Separate tables have been provided region and segment wise for quick grasp of the facts and estimates. This report also gives a multi-dimensional perspective of the weight management services industry.

Scope and Overview

The objective of the study on “Weight Management Services Market: Global Analysis and Forecast” is to gain detailed market insights for key Weight Management Services segments. The market is analyzed on the basis of growth trends, ongoing developments, market penetration and revenue share. The report also covers the strategies followed by “Weight Management Services Market” players.
Global Weight Management Market is estimated to be USD 385.1 billion in 2010 and expected to reach USD 650.9 billion in 2015 at a CAGR of 9.4% over the period 2010 to 2015. Equipment & Devices segment accounted for the largest share at 37.7% of weight management market in 2010. Weight management services will be the fastest growing segment at 13.4% CAGR during 2010 to 2015. Weight management services segment will be worth USD 205.2 billion in 2015.
Weight management industry is expected to touch a USD 650 billion mark by the year 2015. This industry is the key to open doors for opportunities for the not only the overweight and obese people, but also the health conscious individuals. This report provides a multi-dimensional view of the “weight management services” that are a subset of the weight management industry. This subsector consists of professional services, slimming centers and hospitals involved in the weight loss procedures such as invasive and non-invasive surgeries.
In the realm of weight management services, there exists a limitless possibility that propels this segment to grow at CAGR of 13.5% (2007 – 2015E) and in value terms USD 200 billion by 2015. This is a major contributor in the weight management services industry with 35% of total potential. Other subsectors contributing to the remaining stake of 65% includes weight loss drugs, supplements, diet foods, replacement foods, beverages, and exercise devices and equipment.
North America is the leader in terms of global market share and growth in the weight management industry with revenue market revenue of USD 147.8 billion in 2010. Second rung is Europe with many people opting for weight management programs in the recent times and this region is growing at a comparable growth rate of North America.
The Asia has the most promising growth potential for the weight management industry in the near-and-far future is where the people are aggressively opting for westernized lifestyles and at the same time has access to more disposable incomes. However, our studies reveal that the Asians are quickly opting for health awareness initiatives making this market more attractive for the companies in this industry.
Contact
Ms Amita
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

» Read More...

How to Include an RSS Feed in Blogs at Blogger/Blogspot


RSSinclude.com makes it very easy to include RSS feeds in your blog. Basically there are two areas on blogs where you can add an RSS box:
1) in the sidebar on the right side (containing the Blog Archive, About me and Followers...)
or
2) in blog posts.
We would like to explain both in the following sections.

1) RSSbox in the Sidebar of the Blog

This area of your blog is visible permanently. You can add a blog archive, your personal bio and much more to this area. Of course you can put an RSSbox from RSSinclude.com here. This is how:
 
a) Log in to your account at blogger.com. On top of the page there is a main menu. Click the "Layout" link, this will lead you to a graphical overview of your blog.
 
b) Click the "Add a Gadget" link. A new window will be opened displaying different gadgets from which you can choose. Select "HTML/JavaScript" to add third-party code like ours.
 
c) A form will appear which contains two form fields: title and content. You can type in a title for the gadget, e.g. "Latest RSS News".
d) The content of the gadget comes fromRSSinclude.com. You should keep rssinclude.com opened in a new window simultaneously. In order to get your IncludeCode you have to create a new RSSbox first. As soon as you are done you will get an IncludeCode by clicking on "Include!".
e) Copy the IncludeCode of your RSSbox and paste it into the form at blogger.com (see screenshot).
f) Click the "Save" button to return to your blog administration.
 
g) You can click the "Preview" button to preview your changes or save the change layout by clicking the "Save" button.
 
h) Click the "View Blog" link (next to the "Monetize" tab) in the blogger administration. Subsequently your blog will be displayed containing a brand new RSSbox. You can still change the styling of the RSSbox at My RSSboxes. If you play around a bit you will be able to embed it very nicely.
 
 

2) RSSbox in a Blog Post

The second way of including an RSS feed in your blog is to embed it into a blog post. The following steps and screenshots show you how to do that:
 
a) Go to your blog administration atblogger.com. Click the "Posting" tab on top of the page. Edit the post in which you want the RSS feed to be displayed - or simply create a new post.
b) Click the "Edit Html" link on top of the rich-text editor. Subsequently the html code of you post will be displayed.
 
c) Open rssinclude.comsimultaneously in a new window. Click the "Create a Box" link. Create and style your RSSbox as you wish. Keep in mind that its dimensions should fit into your blog post. As soon as you are done go to the "Include!" tab (see screenshot).
 
d) Copy and paste the JavaScript-code from rssinclude.com into the html of your blog post. Ensure that you paste the code in a spare line of the editor (see screenshot).
e) Click the "Publish Post" link. Blogger.com should now say "Your  blog post published successfully!". Click the "View Blog" link to display your changes.
 

f) This is how your blog post could look like. You can still change the styling of the RSSbox by surfing to My RSSboxes at rssinclude.com.

» Read More...

Search This Blog

About Me

My photo

The dedicated team of researchers and analysts at Business Research Industry into the Advantage of Knowledge for your company. Data becomes knowledge through the application of Dolcera's optimization process as follows.

Archives

Business Research Industry. Powered by Blogger.